What stands out to me about this research report is that they aren't expecting a US launch until 2015 - with the delays that plague this company (I've held for 5 yrs), that isn't good news and might not eventuate till later than 2015.
European exposure is great, but the US is where money is made in pharma - and yes this is a 'device' but it's still very much under the banner of pharma.
Could be a long wait to get to the top for TIS.
EU approval will see a price spike though - don't think otherwise.
I just hope that after EU they really push very hard to break into the US market.
DYOR
TIS Price at posting:
43.0¢ Sentiment: LT Buy Disclosure: Held
